AricDParnesMD

Instructor, Medicine-Brigham and Women's Hospital and Dana-Farber Cancer Institue, Harvard Medical School

Dr. Parnes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2001 - 2004
University of Dublin Trinity CollegeClass of 2001

PubMed

53 citations
A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies.
Hanny Al-Samkari, Aric Parnes, Katayoon Goodarzi, James I Weitzman, Jean M. Connors
Haematologica. 2020-06-04
66 citations
A systematic review of religious beliefs about major end-of-life issues in the five major world religions.
Rajshekhar Chakraborty, Areej El-Jawahri, Mark R. Litzow, Karen L. Syrjala, Aric Parnes
Palliative & Supportive Care. 2017-10-01
6 citations
Emicizumab for the treatment of acquired hemophilia A: Retrospective review of a single-institution experience.
Evan C Chen, William Gibson, Paula Temoczko, Nathan T Connell, Robert Handin
Haemophilia. 2023-01-01

Abstracts/Posters

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies
Aric D Parnes, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Improving Rates of Venous Thromboembolism Prophylaxis in Multiple Myeloma Patients on Immunomodulatory Drugs
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018